Amplia Therapeutics Revenue

In the fiscal year ending March 31, 2025, Amplia Therapeutics had annual revenue of 3.78M AUD, down -15.03%. Amplia Therapeutics had revenue of 2.38M in the half year ending March 31, 2025, a decrease of -509.87%.

Revenue

3.78M AUD

Revenue Growth

-15.03%

P/S Ratio

31.83

Revenue / Employee

n/a

Employees

n/a

Market Cap

75.10M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	3.78M	-669.04K	-15.03%
Mar 31, 2024	4.45M	3.26M	274.34%
Mar 31, 2023	1.19M	-793.83K	-40.03%
Mar 31, 2022	1.98M	449.80K	29.33%
Mar 31, 2021	1.53M	1.50M	4,380.44%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo, Inc.	1.73B
Veradigm	588.02M
Elite Pharmaceuticals	84.04M
Tian'an Technology Group	1.78M
Glass House Brands	215.62M
American Oncology Network	1.76B
Northwest Biotherapeutics	1.47M
Silence Therapeutics	27.70M

Revenue Rankings